Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Lung Neoplasms 1Leukemia 1Glioblastoma 1Disease 1Carcinoma, Non-Small-Cell Lung 1Advanced Gastric Cancer 1

Interventions

Oxaliplatin 200Capecitabine 116S 1 (combination) 106Fluorouracil 105Docetaxel 100Cisplatin 88Leucovorin 75Paclitaxel 71Irinotecan 68apatinib 43sintilimab 42Drug Therapy 42Surgical Procedures, Operative 37Hyperthermic Intraperitoneal Chemotherapy 34pembrolizumab 32Radiotherapy 31Trastuzumab 30Gastrectomy 23Nivolumab 22Epirubicin 22Tegafur 21Bevacizumab 21XELOX 20titanium silicide 19camrelizumab 19tislelizumab 17Ramucirumab 17Carboplatin 16Neoadjuvant Therapy 15Endoscopic Mucosal Resection 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Stomach Neoplasms × Drug Therapy, Combination × Clear all
NCT05908838 2023-06-18

Clinical Study of Modified Banxia Xiexin Decoction Treatment on Gastric Cancer

ShuGuang Hospital

Phase EARLY_PHASE1 Completed
146 enrolled
Gastrointestinal

Disease, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡